Clinical trials for Angioedema

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Angioedema. For all clinical trials, go to clinical trials search

This list shows clinical trials for Angioedema

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Angioedema
Title Recruitment status Location
A Phase 3, Multicenter, Randomized, Single-Blind, Dose-Ranging, Crossover Study to Evaluate the Safety and Efficacy of Intravenous Administration of CINRYZE® (C1 Esterase Inhibitor [Human]) for the Prevention of Angioedema Attacks in Children 6 to 11 Years of Age With Hereditary Angioedema Recruiting United Kingdom
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS) Recruiting United Kingdom
A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients Recruiting United Kingdom
Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264 Recruiting United Kingdom
Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema Recruiting United Kingdom
AWARE - Chronic Urticaria Recruiting United Kingdom
Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema Not recruiting United Kingdom
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study Evaluating the Safety and Efficacy of Icatibant as a Treatment for Angiotensin-Converting Enzyme Inhibitor (ACE-I)-Induced Angioedema in Adults Not Recruiting United Kingdom
A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema Not recruiting United Kingdom
Open-Label, Multicenter Study to Evaluate Safety, Local Tolerability, Convenience, and Efficacy of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema - EASSI - Evaluation of the Safety of Self-administration with Icatibant Not Recruiting United Kingdom

Page last reviewed:

Next review due: